Advent Capital Management »

Arrowhead Pharmaceuticals In Note 1/1 shares owned by Advent Capital Management

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals In Note 1/1 shares owned by Advent Capital Management from 13F filings

Historical chart of Advent Capital Management investment in Arrowhead Pharmaceuticals In Note 1/1

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals In Note 1/1 held by Advent Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals In Note 1/1 by Advent Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $21M 18M 1.20

More positions owned by Advent Capital Management

Bank Of America Corp Conv Pfd (BAC.PL)
Wells Fargo & Company Conv Pfd (WFC.PL)
Uber Technologies Conv (Principal)
Doordash Conv (Principal)
Nextera Energy Conv Pfd (NEE.PS)
Cms Energy Corp Conv (Principal)
Ppl Capital Funding Conv (Principal)
Global Payments Conv (Principal)
Alphabet Conv Pfd
Akamai Technologies Conv (Principal)
Kkr & Co Conv Pfd (KKR.PD)
Western Digital Corp Conv (Principal)
Aerovironment Conv (Principal)
Apollo Global Management Conv Pfd (APO.PA)
Snowflake Conv (Principal)

View all positions for Advent Capital Management

Top funds holding Arrowhead Pharmaceuticals In Note 1/1

Deerfield Management Company
Camden Asset Management
LMR Partners
Linden Advisors
Ubs Global Asset Management Americas
Readystate Asset Management
Lazard Asset Management
Calamos Advisors
MacKay Shields
DeepCurrents Investment Group
Context Capital Management
Advent Capital Management
State Street Corporation
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Oaktree Capital Management

View all funds holding Arrowhead Pharmaceuticals In Note 1/1